Interventional oncology and immunotherapy: current status and future perspectives DOI Creative Commons

Ji Ma,

Zhigang Wei,

Xin Ye

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: April 8, 2025

Interventional oncology has become an important part of multidisciplinary cancer treatment following the development interventional radiology. Tumors can release antigens, activate immunity, and cause abscopal effect after therapy. However, activated immune response is limited involves a complex process. New methods to solve problems were developed advent immunotherapy. The combination therapies enhanced antitumor improved patient outcomes with good application prospects. In this review, we have summarized used improve efficacy discussed advancements in combining therapy

Language: Английский

Interventional oncology and immunotherapy: current status and future perspectives DOI Creative Commons

Ji Ma,

Zhigang Wei,

Xin Ye

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: April 8, 2025

Interventional oncology has become an important part of multidisciplinary cancer treatment following the development interventional radiology. Tumors can release antigens, activate immunity, and cause abscopal effect after therapy. However, activated immune response is limited involves a complex process. New methods to solve problems were developed advent immunotherapy. The combination therapies enhanced antitumor improved patient outcomes with good application prospects. In this review, we have summarized used improve efficacy discussed advancements in combining therapy

Language: Английский

Citations

0